BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31358519)

  • 1. Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma.
    Haznadar M; Diehl CM; Parker AL; Krausz KW; Bowman ED; Rabibhadana S; Forgues M; Bhudhisawasdi V; Gonzalez FJ; Mahidol C; Budhu A; Wang XW; Ruchirawat M; Harris CC
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1704-1711. PubMed ID: 31358519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Impact of Desmoplastic Reaction Evaluation for Intrahepatic Cholangiocarcinoma.
    Kojima S; Hisaka T; Midorikawa R; Naito Y; Akiba J; Tanigawa M; Yano H; Akagi Y; Okuda K
    Anticancer Res; 2020 Aug; 40(8):4749-4754. PubMed ID: 32727801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
    Wu C; Bai DS; Jiang GQ; Jin SJ
    World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.
    Shirakawa H; Kuronuma T; Nishimura Y; Hasebe T; Nakano M; Gotohda N; Takahashi S; Nakagohri T; Konishi M; Kobayashi N; Kinoshita T; Nakatsura T
    Int J Oncol; 2009 Mar; 34(3):649-56. PubMed ID: 19212669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Zhang X; Huang WJ; Zhang ML; Wang W; Niu Y; Wang RT; Liu ZY
    BMC Gastroenterol; 2022 Jun; 22(1):288. PubMed ID: 35668355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma.
    Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY
    Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic values of tissue-resident CD8
    Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
    World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma.
    Nishino R; Honda M; Yamashita T; Takatori H; Minato H; Zen Y; Sasaki M; Takamura H; Horimoto K; Ohta T; Nakanuma Y; Kaneko S
    J Hepatol; 2008 Aug; 49(2):207-16. PubMed ID: 18490072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma.
    Dong ZR; Zhang C; Cai JB; Zhang PF; Shi GM; Gao DM; Sun HC; Qiu SJ; Zhou J; Ke AW; Fan J
    Tumour Biol; 2015 Apr; 36(4):2763-71. PubMed ID: 25480415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive Metabolism-Associated Gene Clusters That Are Also Prognostic in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Ding L; Ning S; Hu W; Xue Y; Yu S
    Oxid Med Cell Longev; 2022; 2022():6595989. PubMed ID: 36199423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
    [No Abstract]   [Full Text] [Related]  

  • 12. Overexpression of interleukin-35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection.
    Zhang MX; Gan W; Jing CY; Zheng SS; Zhang J; Shen HJ; Xu X; Lin JJ; Zhang BH; Qiu SJ
    Cancer Sci; 2018 Apr; 109(4):1195-1206. PubMed ID: 29446854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
    Lendvai G; Szekerczés T; Illyés I; Csengeri M; Schlachter K; Szabó E; Lotz G; Kiss A; Borka K; Schaff Z
    PLoS One; 2021; 16(6):e0253065. PubMed ID: 34129628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholangiocarcinoma Heterogeneity Revealed by Multigene Mutational Profiling: Clinical and Prognostic Relevance in Surgically Resected Patients.
    Ruzzenente A; Fassan M; Conci S; Simbolo M; Lawlor RT; Pedrazzani C; Capelli P; D'Onofrio M; Iacono C; Scarpa A; Guglielmi A
    Ann Surg Oncol; 2016 May; 23(5):1699-707. PubMed ID: 26717940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Murakami Y; Kubo S; Tamori A; Itami S; Kawamura E; Iwaisako K; Ikeda K; Kawada N; Ochiya T; Taguchi YH
    Sci Rep; 2015 Nov; 5():16294. PubMed ID: 26538415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor.
    Sasaki M; Tsuneyama K; Ishikawa A; Nakanuma Y
    Hum Pathol; 2003 Dec; 34(12):1337-44. PubMed ID: 14691921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
    Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
    J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of integrin ανβ6 differentiates perihilar cholangiocarcinoma (PHC) from benign disease mimicking PHC.
    Franken LC; Vuijk FA; Soer EC; Roos E; Erdmann JI; Hooijer GKJ; Vahrmeijer AL; Gambhir SS; van Gulik TM; Sarasqueta AF; Verheij J; Swijnenburg RJ
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):628-634. PubMed ID: 33069505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.
    Scarlett CJ; Saxby AJ; Nielsen A; Bell C; Samra JS; Hugh T; Baxter RC; Smith RC
    Hepatology; 2006 Sep; 44(3):658-66. PubMed ID: 16941699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.